

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pulmonary arterial hypertension | D000081029 | — | — | — | 1 | 1 | — | — | 2 |
| Drug common name | Seralutinib |
| INN | seralutinib |
| Description | Seralutinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target platelet-derived growth factor receptor beta and platelet-derived growth factor receptor alpha. |
| Classification | Small molecule |
| Drug class | tyrosine kinase inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC |
| PDB | — |
| CAS-ID | 1619931-27-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4650333 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 3P63ZTE3OY (ChemIDplus, GSRS) |
